Cardiometabolic Risk Factors Assessed by a Finger Stick Dried Blood Spot Method

Background: Cardiovascular and metabolic risk factors are gaining attention as potential indicators for intervention in the prevention and treatment of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Blood spot technology offers an efficient, convenient method to measure these risk factors in an at-risk population. Simple and convenient methods to assess cardiometabolic risk factors will allow clinicians to formulate treatment strategies for effective prevention and management of these conditions. Method: Insulin and high sensitivity C-reactive protein (hs-CRP) were measured in dried blood spot and corresponding serum samples using conventional commercial serum kits based on a direct sandwich ELISA technique. The triglyceride assay involved enzymatic hydrolysis of triglycerides by lipase to glycerol and free fatty acids. The glycerol produced was then measured by coupled enzyme reactions. Blood spot assays were modified from previously published methods to give improved accuracy and turnaround time. Results: Blood spot levels correlated well with serum levels of hs-CRP (r = 0.99), triglycerides (fasting, r = 0.95; nonfasting, r = 0.94), and insulin (fasting, r = 0.93; nonfasting, r = 0.97). Conclusion: Blood spot testing for insulin, hs-CRP, and triglycerides may be helpful in the cardiometabolic screening or monitoring of patients at risk of developing CVD, T2DM, or metabolic syndrome.

[1]  J. Hokanson,et al.  Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.

[2]  D. Sprecher.  Triglycerides as a risk factor for coronary artery disease. , 1998, The American journal of cardiology.

[3]  F. Messerli,et al.  Diabetes, hypertension, and cardiovascular disease: an update. , 2001, Hypertension.

[4]  D. Prabhakaran,et al.  Use of filter paper stored dried blood for measurement of triglycerides , 2006, Lipids in Health and Disease.

[5]  A. Hattersley,et al.  Development of a bloodspot assay for insulin. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[6]  E. Frohlich,et al.  Diabetes, Hypertension, and Cardiovascular Disease: An Update , 2001, Hypertension.

[7]  J. Elborn,et al.  C-reactive protein measured in dried blood spots from patients with cystic fibrosis. , 1991, Journal of immunological methods.

[8]  Paul M. Ridker,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003 .

[9]  J. Ruidavets,et al.  Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. , 2002, Diabetes care.

[10]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[11]  Nancy R Cook,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.

[12]  K. Watson.  Managing cardiometabolic risk: an evolving approach to patient care. , 2007, Critical pathways in cardiology.

[13]  A. Gotto.  Triglyceride as a risk factor for coronary artery disease. , 1998, The American journal of cardiology.

[14]  D. Hougaard,et al.  Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. , 2005, Clinical chemistry.

[15]  T. McDade,et al.  High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. , 2004, Clinical chemistry.

[16]  A. A. Al Serouri,et al.  Measurement of C-reactive protein in dried blood sports on filter paper. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  L. Pescatello,et al.  Physical activity mediates a healthier body weight in the presence of obesity , 2000, British journal of sports medicine.

[18]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[19]  M. Smith,et al.  Quantification of insulin in dried blood spots. , 1998, The Journal of laboratory and clinical medicine.